Empowering Clinical Research in a Distributed World

Many Contract Research Organizations (CROs) and Sponsors are applying technology to enhance clinical trials, resulting in improvements like faster and more representative trial enrollment, and better participant experiences. Since COVID-19, particular attention is being paid to ‘decentralized’ clinical trials (DCT) and hybrid clinical trials. Effective modernization of trials requires understanding of clinical research and supporting technologies. Supporting the shift to DCT and hybrid trials also places significant demand on data management, infrastructure, and its integration to facilitate increasingly complex trial design, analytics and enhancement needs. In this session, Khondoker Huq and Jeff Kenkel will discuss: - What organizations are doing to capture the full value of their clinical research data – wherever the data is generated - Benefits of Decentralized and Hybrid Clinical Trials - Challenges facing adoption of DCT and Hybrid Trials - Organizations supporting DCT standards and advancements - Complexity of technology solutions with IoT analytics - Intelligent technologies that allow for data collection from ‘edge-to-core’ and communication out to trial participants and other trusted third parties